Integrilin and Tenecteplase in Acute Myocardial Infarction - INTEGRITI

Description:

The goal of the Integrilin and Tenecteplase in Acute Myocardial Infarction (INTEGRITI) trial was to evaluate the efficacy of combining eptifibatide with reduced-dose tenecteplase (TNK) in patients with ST-elevation myocardial infarction.